BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator

No drug-related safety signals identified by the independent Data and Safety Monitoring Board.
MORRISTOWN, N.J., Nov. 15, 2020 (GLOBE NEWSWIRE) — BioAegis Therapeutics Inc., a clinical stage, priva‚Ķ [read more]

Leave a Comment